Lobbying client

HALOZYME THERAPEUTICS INC

U.S. Biotechnology Company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
32
Filed by
2
Reported in-house
—
Reported by firms
$930,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2026

Filings

32 filings, newest first.
Filing Filed by Amount
3rd Quarter - Report
3rd Quarter 2026
FORBES-TATE $80,000 reported
2nd Quarter - Report
2nd Quarter 2026
FORBES-TATE $80,000 reported
1st Quarter - Report
1st Quarter 2026
FORBES-TATE $70,000 reported
4th Quarter - Report
4th Quarter 2025
FORBES-TATE $60,000 reported
3rd Quarter - Report
3rd Quarter 2025
FORBES-TATE $60,000 reported
2nd Quarter - Report
2nd Quarter 2025
FORBES-TATE $60,000 reported
1st Quarter - Report
1st Quarter 2025
FORBES-TATE $60,000 reported
4th Quarter - Report
4th Quarter 2024
FORBES-TATE $60,000 reported
3rd Quarter - Report
3rd Quarter 2024
FORBES-TATE $60,000 reported
2nd Quarter - Report
2nd Quarter 2024
FORBES-TATE $60,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FORBES-TATE 29 $930,000
FOLEY & LARDNER LLP 2 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 21
Medicare/Medicaid MMM 18
Science/Technology SCI 10
Budget/Appropriations BUD 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 925 116th 2
H.R. 5376 118th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.